In gemcitabine-resistant cells, GSTM3TV2 promoted the drug resistance by sponging let-7 for upregulating L-type amino acid transporter 2 (LAT2) and oxidized low-density lipoprotein receptor 1 (OLR1) in pancreatic cancer cells (120). This evidence concerns the gene OLR1 and pancreatic neoplasm.